Stress and the Impact of Personalized Medicine

Charles F. Gillespie; Elisabeth B. Binder; Paul E. Holtzheimer; Charles B. Nemeroff

doi:10.1093/acprof:oso/9780195393804.003.0005

Stress and the Impact of Personalized Medicine

Charles F. Gillespie, Elisabeth B. Binder, Paul E. Holtzheimer, Charles B. Nemeroff

Psychiatry & Behavioral Sciences

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

This report summarizes a number of the epigenetic influence on the development and treatment of anxiety and mood disorders. The focus taken here is on the impact of stress and stressors on the endocrine axis and their effects on the anxiety and mood disorders. There have been a number of interesting leads as to what the relevant important genetic components may be however none have been studied sufficiently to be used as Personalized Medicine markers for anxiety or depression.

Original language	English (US)
Title of host publication	Integrative Neuroscience and Personalized Medicine
Publisher	Oxford University Press
ISBN (Electronic)	9780199863495
ISBN (Print)	9780195393804
DOIs	https://doi.org/10.1093/acprof:oso/9780195393804.003.0005
State	Published - Jan 1 2011

Keywords

Abuse
Anxiety
Brain imaging
Depression
Genes
Ghypothalamic-pituitary-adrenal axis
Neuroendocrine
SNPs
Stress
Stressors

ASJC Scopus subject areas

Neuroscience(all)

Access to Document

10.1093/acprof:oso/9780195393804.003.0005

Fingerprint Dive into the research topics of 'Stress and the Impact of Personalized Medicine'. Together they form a unique fingerprint.

Cite this

Gillespie, C. F., Binder, E. B., Holtzheimer, P. E., & Nemeroff, C. B. (2011). Stress and the Impact of Personalized Medicine. In Integrative Neuroscience and Personalized Medicine Oxford University Press. https://doi.org/10.1093/acprof:oso/9780195393804.003.0005

@inbook{70457045a5664a9b8076ad4919635b9e,

title = "Stress and the Impact of Personalized Medicine",

abstract = "This report summarizes a number of the epigenetic influence on the development and treatment of anxiety and mood disorders. The focus taken here is on the impact of stress and stressors on the endocrine axis and their effects on the anxiety and mood disorders. There have been a number of interesting leads as to what the relevant important genetic components may be however none have been studied sufficiently to be used as Personalized Medicine markers for anxiety or depression.",

keywords = "Abuse, Anxiety, Brain imaging, Depression, Genes, Ghypothalamic-pituitary-adrenal axis, Neuroendocrine, SNPs, Stress, Stressors",

author = "Gillespie, {Charles F.} and Binder, {Elisabeth B.} and Holtzheimer, {Paul E.} and Nemeroff, {Charles B.}",

year = "2011",

month = jan,

day = "1",

doi = "10.1093/acprof:oso/9780195393804.003.0005",

language = "English (US)",

isbn = "9780195393804",

booktitle = "Integrative Neuroscience and Personalized Medicine",

publisher = "Oxford University Press",

}

TY - CHAP

T1 - Stress and the Impact of Personalized Medicine

AU - Gillespie, Charles F.

AU - Binder, Elisabeth B.

AU - Holtzheimer, Paul E.

AU - Nemeroff, Charles B.

PY - 2011/1/1

Y1 - 2011/1/1

N2 - This report summarizes a number of the epigenetic influence on the development and treatment of anxiety and mood disorders. The focus taken here is on the impact of stress and stressors on the endocrine axis and their effects on the anxiety and mood disorders. There have been a number of interesting leads as to what the relevant important genetic components may be however none have been studied sufficiently to be used as Personalized Medicine markers for anxiety or depression.

AB - This report summarizes a number of the epigenetic influence on the development and treatment of anxiety and mood disorders. The focus taken here is on the impact of stress and stressors on the endocrine axis and their effects on the anxiety and mood disorders. There have been a number of interesting leads as to what the relevant important genetic components may be however none have been studied sufficiently to be used as Personalized Medicine markers for anxiety or depression.

KW - Abuse

KW - Anxiety

KW - Brain imaging

KW - Depression

KW - Genes

KW - Ghypothalamic-pituitary-adrenal axis

KW - Neuroendocrine

KW - SNPs

KW - Stress

KW - Stressors

UR - http://www.scopus.com/inward/record.url?scp=84920752641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920752641&partnerID=8YFLogxK

U2 - 10.1093/acprof:oso/9780195393804.003.0005

DO - 10.1093/acprof:oso/9780195393804.003.0005

M3 - Chapter

AN - SCOPUS:84920752641

SN - 9780195393804

BT - Integrative Neuroscience and Personalized Medicine

PB - Oxford University Press

ER -